Regional Monitoring EECA
by ECUO PLWH
Regional Monitoring EECA
Showing 1-13 of 13 items.
| # | Country | Source of financing | Manufacturer | Tradename | INN | Form | Price per unit ($) | Units in purchase | Units in package | Price per package ($) | Packages in purchase | Price per purchase ($) | Distributor | Year | Purchase date | Delivery date | Registered | In the list of main (vital) medications | WHO prequalification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Republic of Armenia | Global Fund | Aurobindo Pharma Ltd. | Didanosine | 250mg caps | 0.4 | 480 | 30 | 12 | 16 | 192 | VPP, through Partnership for Supply Chain Management (PFSCM) | 2015 | 2015-03-11 | 2015-10-14 | Not specified | Not specified | Not specified | |
| 2 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 250mg caps | 1.1287 | 475500 | 30 | 33.86 | 15850 | 536681 | 2015 | Not specified | Not specified | Not specified | |||
| 3 | Republiс of Azerbaijan | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 250mg caps | 0.9503 | 17490 | 30 | 28.51 | 583 | 16621.33 | 2015 | Yes | Yes | Not specified | |||
| 4 | Republic of Latvia | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 6.1753 | 120 | 120 | 741.03 | 1 | 741.03 | 2015 | Not specified | Not specified | Not specified | |||
| 5 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 250mg caps | 2.375 | 3200 | 40 | 95 | 80 | 7600 | 2015 | Not specified | Not specified | Not specified | |||
| 6 | Russian Federation | Government | Bristol-Myers Squibb | Videx | Didanosine | 250mg caps | 0.97 | 93450 | 30 | 29.1 | 3115 | 90646.5 | 2016 | Not specified | Yes | Not specified | |||
| 7 | Russian Federation | Government | Aurobindo Pharma Ltd. | Didanosine | Didanosine | 250mg caps | 1.128 | 515760 | 30 | 33.84 | 17192 | 581777.25 | 2015 | Not specified | Not specified | Not specified | |||
| 8 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 250mg caps | 0.8638 | 36000 | 100 | 86.38 | 360 | 31096.8 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Yes | ||
| 9 | Republic of Latvia | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 250mg caps | 2.7135 | 40 | 40 | 108.54 | 1 | 108.54 | 2015 | Not specified | Not specified | Not specified | |||
| 10 | Republic of Poland | Government | ViiV Healthcare | Retrovir | Zidovudine (AZT or ZDV) | 250mg caps | 2.375 | 22000 | 40 | 95 | 550 | 52250 | 2015 | Not specified | Not specified | Not specified | |||
| 11 | Russian Federation | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 7.01 | 61920 | 120 | 841.2 | 516 | 434059.19 | 2016 | Yes | Yes | Not specified | |||
| 12 | Russian Federation | Government | Boehringer Ingelheim | Aptivus | Tipranavir | 250mg caps | 6.3308 | 36000 | 120 | 759.7 | 300 | 227910 | 2015 | Not specified | Not specified | Not specified | |||
| 13 | Republic of Poland | Government | GlaxoSmithKline | Retrovir | Zidovudine (AZT or ZDV) | 250mg caps | 11.246 | 150 | 5 | 56.23 | 30 | 1686.9 | Krajowe Centrum ds. AIDS | 2016 | Yes | Yes | Yes |